{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:57Z","timestamp":1786119297373,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/ftd.0b013e3181c324c8","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T03:35:39Z","timestamp":1264131339000},"page":"102-106","source":"Crossref","is-referenced-by-count":43,"title":["A Novel HPLC Method for Quantification of 10 Antiepileptic Drugs or Metabolites in Serum\/Plasma Using a Monolithic Column"],"prefix":"10.1097","volume":"32","author":[{"given":"Courtney","family":"Heideloff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin R","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","article-title":"Therapeutic drug monitoring of old and newer anti-epileptic drugs.","volume":"42","author":"Neels","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer antiepileptic drugs.","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s002280050001","article-title":"Therapeutic monitoring of the new antiepileptic drugs.","volume":"55","author":"Tomson","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1085\/jgp.200810081","article-title":"Pentobarbital produces activation and block of {alpha}1{beta}2{gamma}2S GABAA receptors in rapidly perfused whole cells and membrane patches: divergent results can be explained by pharmacokinetics.","volume":"133","author":"Gingrich","year":"2009","journal-title":"J Gen Physiol"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/FTD.0b013e3181678ecb","article-title":"High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry.","volume":"30","author":"Subramanian","year":"2008","journal-title":"Ther Drug Monit"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2007.06.023","article-title":"Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, ox carbazepine and zonisamide in serum after solid-phase extraction.","volume":"857","author":"Vermeij","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bmc.117","article-title":"Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography.","volume":"16","author":"Levert","year":"2002","journal-title":"Biomed Chromatogr"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2005.09.009","article-title":"Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.","volume":"828","author":"Contin","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(01)00328-0","article-title":"Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients.","volume":"762","author":"Mandrioli","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/chromsci\/45.9.616","article-title":"Drug monitoring: Simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam.","volume":"45","author":"Greiner-Sosanko","year":"2007","journal-title":"J Chromatogr Sci"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1365\/s10337-006-0157-7","article-title":"Isocratic reversed-phase HPLC for simultaneous separation and determination of seven antiepileptic drugs and two of their active metabolites in human plasma.","volume":"65","author":"Ma","year":"2007","journal-title":"Chromatographia"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/bmc.753","article-title":"Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography.","volume":"21","author":"Greiner-Sosanko","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jpba.2006.02.044","article-title":"Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography.","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.chroma.2007.11.118","article-title":"Particle packed columns and monolithic columns in high-performance liquid chromatography-comparison and critical appraisal.","volume":"1184","author":"Unger","year":"2008","journal-title":"J Chromatogr A"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/clinchem\/43.8.1468","article-title":"Oxaprozin and 5-(p-hydroxyphenyl)-5-phenylhydantoin interference in phenytoin immunoassays.","volume":"43","author":"Datta","year":"1997","journal-title":"Clin Chem"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.ftd.0000164315.13825.dd","article-title":"Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue.","volume":"27","author":"Datta","year":"2005","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3181c324c8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:12:54Z","timestamp":1786039974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201002000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181c324c8","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}